References
1
Bringmann G.
Günther G.
Ochse M.
Schupp O.
Tasler S. In Progress in the Chemistry of Natural Products
Vol. 82:
Herz W.
Falk H.
Kirby GW.
Moore RE.
Tamm C.
Springer-Verlag;
New York:
2001.
2
Lloyd-Williams P.
Giralt E.
Chem. Soc. Rev.
2001,
30:
145
3
Ayres DC.
Loike JD. In Chemistry and Pharmacology of Natural Products, Lignans: Chemical, Biological and Clinical Properties
Phillipson JD.
Ayres DC.
Baxter H.
Cambridge University Press;
Cambridge:
1990.
4
Tomioka K.
Ishiguro T.
Iitaka Y.
Koga K.
Tetrahedron
1984,
40:
1303
5
Robin JP.
Gringore O.
Brown E.
Tetrahedron Lett.
1980,
21:
2709
6
Meyers AI.
Flisak JR.
Aitken RA.
J. Am. Chem. Soc.
1987,
109:
5446
7a
Uemura M.
Daimon A.
Hayashi Y.
J. Chem. Soc., Chem. Commun.
1995,
1943
7b
Monovich LG.
Le Huérou Y.
Rönn M.
Molander GA.
J. Am. Chem. Soc.
2000,
122:
52
8
Nicolaou KC.
Li H.
Boddy CNC.
Ramanjulu JM.
Yue T.-Y.
Natarajan S.
Chu X.-J.
Bräse S.
Rübsam F.
Chem. Eur. J.
1999,
5:
2584
9a
Cammidge AN.
Crépy KVL.
Chem. Commun.
2000,
1723
9b
Yin J.
Buchwald S.
J. Am. Chem. Soc.
2000,
122:
12051
9c
Herrbach A.
Marinetti A.
Baudoin O.
Guénard D.
Guéritte F.
J. Org. Chem.
2003,
68:
4897
10
Lipshutz BH.
Keith JM.
Angew. Chem. Int. Ed.
1999,
38:
3530
11
Nicolaou KC.
Natarajan S.
Li H.
Jain NF.
Hughes R.
Solomon ME.
Ramanjulu JM.
Boddy CNC.
Takayanagi M.
Angew. Chem. Int. Ed.
1998,
37:
2708
12a
Baudoin O.
Cesario M.
Guénard D.
Guéritte F.
J. Org. Chem.
2002,
67:
1199
12b
Baudoin O.
Claveau F.
Thoret S.
Herrbach A.
Guénard D.
Guéritte F.
Bioorg. Med. Chem.
2002,
10:
3395
13
Ziegler FE.
Schwartz JA.
J. Org. Chem.
1978,
43:
985
14
Wilson CV.
Janssen DE.
Org. Synth., Coll. Vol. IV
Wiley;
New York:
1963.
p.547
15
Baudoin O.
Guénard D.
Guéritte F.
J. Org. Chem.
2000,
65:
9268
16a
Wolfe JP.
Buchwald SL.
Angew. Chem. Int. Ed.
1999,
38:
2413
16b
Wolfe JP.
Singer RA.
Yang BH.
Buchwald SL.
J. Am. Chem. Soc.
1999,
121:
9550
17
Corey EJ.
Bakshi RK.
Shibata S.
J. Am. Chem. Soc.
1987,
109:
5551
18 (+)-3: [α]D
23 +38.8 (c 1.1, CHCl3); HPLC (Chiracel OD, hexane-EtOH, 95:5, 1.0 mL/min) t
R 7.8 min (minor enantiomer), 9.2 min (major enantiomer).
19
Hashiguchi S.
Fujii A.
Haack K.-J.
Matsumura K.
Ikariya T.
Noyori R.
Angew. Chem., Int. Ed. Engl.
1997,
36:
288
20 Compound (-)-2d: mp 70 °C; [α]D
24 -21.4 (c 1.0, CHCl3); HPLC (C18 Symmetry column, H2O-CH3CN, 35:65, 1.0 mL/min) t
R
16.6 min (diastereoisomer 1, 4%), 17.9 min (diastereoisomer 2, 96%); HPLC (Chiralpak AD, heptane-i-PrOH, 98:2, 1.0 mL/min) diastereoisomer 2: t
R
10.8 min (enantiomer 1, 5%), 24.5 min (enantiomer 2, 95%), diastereoisomer 1: t
R
11.4 min (enantiomer 1, 95%), 13.0 min (enantiomer 2, 5%). 1H NMR [300 MHz, (CD3)2CO]
δ = 1.15 (d, J = 6.3 Hz, 3 H), 3.23 (s, 3 H), 3.61 (s, 3 H), 3.74 (s, 3 H), 3.89 (s, 3 H), 4.15 (d, J = 12.0 Hz, 1 H), 4.21 (d,
J = 12.0 Hz, 1 H), 4.25 (q, J = 6.5 Hz, 1 H), 4.33 (d, J = 12.3 Hz, 1 H), 4.45 (d, J = 12.3 Hz, 1 H), 4.57 (s, 2 H), 6.04 (s, 1H), 6.06 (s, 1 H), 6.63 (s, 1 H), 6.98 (s, 1 H), 7.12 (s, 1 H), 7.20-7.32 (m, 5 H) (major diastereoisomer). 13C NMR [75.5 MHz, (CD3)2CO] δ = 23.9, 55.3, 56.2, 60.9, 61.0, 67.7, 70.8, 74.9, 96.7, 102.1, 105.9, 108.7, 111.0, 126.6, 127.7, 127.9, 128.5, 128.9, 133.5, 138.4, 140.7, 142.5, 147.2, 148.6, 151.2, 154.1 (major diastereoisomer). HRMS (ESI): m/z for [(M + Na)+] calcd for C28H32NaO8: 519.1995; found: 519.1982.
21 Crystallographic data for 2d have been deposited with the Cambridge Crystallographic Data Center under number CCDC-203288.
For related examples:
22a
Munoz MP.
Martin-Matute B.
Fernandez-Rivas C.
Cardenas DJ.
Echavarren AM.
Adv. Synth. Cat.
2001,
343:
338
22b
Fernandez-Rivas C.
Cardenas DJ.
Martin-Matute B.
Monge A.
Gutierrez-Puebla E.
Echavarren AM.
Organometallics
2001,
20:
2998